ProMetic Life Sciences News
Most Popular ProMetic Life Sciences Story
Abraxis, ProMetic ink $295M deal for four drugs
Abraxis has signed a $295M licensing deal with ProMetic Life Sciences to develop and market four biotech drugs. The companies didn't say which programs they woud be collaborating on, only that the Read more...
Latest Headlines
- September 5, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
